WO2015150694A1 - Composition cosmetique pour l'eclaircissement de la peau - Google Patents
Composition cosmetique pour l'eclaircissement de la peau Download PDFInfo
- Publication number
- WO2015150694A1 WO2015150694A1 PCT/FR2015/050834 FR2015050834W WO2015150694A1 WO 2015150694 A1 WO2015150694 A1 WO 2015150694A1 FR 2015050834 W FR2015050834 W FR 2015050834W WO 2015150694 A1 WO2015150694 A1 WO 2015150694A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polyamide
- particles
- skin
- composition
- composition according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/0279—Porous; Hollow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/88—Polyamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
Definitions
- the present invention relates to a cosmetic composition for lightening the skin, its method of manufacture and its use.
- Glabridin the main component of the hydrophobic fraction of licorice root extracts (Glycyrrhiza glabra), is known for its lightening and depigmenting effects on the skin. Nevertheless, this substance is difficult to formulate in cosmetic products, in particular because of its solubility limited to certain alcoholic solvents.
- WO 98/58628 relates to a cosmetic composition for lightening or whitening of the skin.
- the composition comprises a bleaching agent, an exfoliant, a particulate adsorbent or absorbent vehicle for the exfoliant and a cosmetic base comprising a film-forming agent.
- WO 2006/037665 discloses an anhydrous cosmetic composition
- a pulverulent phase comprising polyamide particles, a fatty phase and at least one active compound sensitive to moisture.
- the intended uses are, for example, the care of oily skin or the whitening of the skin.
- the document WO 96/21422 describes an anhydrous cosmetic composition
- an anhydrous cosmetic composition comprising a polar active dermatological agent, a vehicle particulate adsorbent or absorbent for this agent, and a hydrophobic cosmetic base.
- US 2002/0176843 discloses the use of polyamide particles as an anti-irritant, especially in compositions further comprising an irritant.
- EP 1493433 discloses porous particles loaded with cosmetic or pharmaceutical active compounds.
- Document FR 2944443 describes a process for producing polyamide-based loose powder particles comprising a cosmetic or pharmaceutical agent.
- the invention firstly relates to a composition
- a composition comprising:
- a support comprising porous polyamide particles having a BET specific surface area greater than or equal to 8 m 2 / g;
- the composition is in powder form, preferably in the form of unaggregated or agglomerated powder.
- the Glycyrrhiza glabra root extract is combined with a solvent, the solvent preferably being an alcohol and more preferably butylene glycol.
- the composition comprises from 50 to 90% by weight of polyamide particles and from 10 to 50% by weight of active mixture, preferably from 70 to 80% by weight of polyamide particles and from 20 to 30% by weight of active mixture, relative to the total weight of the composition.
- the polyamide of the particles comprises units of polyamide 12, preferably comprises a molar content of polyamide units 12 of 50 to 100%, more particularly preferably of 80 to 100%; the polyamide particles being preferably selected from particles of polyamide 12, copolyamide 6/12, copolyamide 8/12, copolyamide 10/12 and mixtures thereof.
- the polyamide particles are obtained by anionic polymerization, optionally by seeding with a mineral or organic filler, lactams and / or lactones in solution and / or suspended in an organic liquid.
- the polyamide particles having an average volume diameter Dv50 of between 3 and 15 ⁇ , preferably between 5 and 12 m.
- BET of the support is chosen in the range from 8 to 30 m 2 / g, preferably from 8 to 20 m 2 / g and for example from 9 m 2 / g to 16 m 2 / g.
- the invention also relates to a cosmetic product comprising the composition according to above in combination with one or more cosmetically acceptable vehicles, additives and / or other active substances.
- the cosmetic product is in the form of a lotion, cream, gel, loose powder, pressed powder or stick.
- the invention also relates to the use of the above composition or the above cosmetic product for lightening the skin, reducing age spots or brown spots on the skin and / or depigmentation of the skin. .
- the invention also relates to a process for preparing the composition according to the invention, comprising:
- the present invention makes it possible to meet the need expressed above.
- it provides cosmetic products for lightening the skin and reducing brown spots or age spots on the skin, the manufacture of which is simplified.
- Glycyrrhiza glabra as active substance with a porous polyamide powder with a relatively high specific surface area.
- the root extract of Glycyrrhiza glabra contains in particular glabridin as the main component of its hydrophobic moiety, which is an active compound which is particularly advantageous for the desired effects.
- the invention offers a time saving and simplification for the formulation of emulsion-type products, and provides a new technical solution for anhydrous products such as pressed powders, free powders, cast products or sticks.
- the diffusion of glabridin into the stratum corneum of the skin and / or the efficacy of glabridin in skin lightening or spot reduction is enhanced by the invention.
- Proportions, percentages or ratios, unless otherwise specified, are by mass.
- the invention provides a composition comprising porous polyamide particles as a carrier and Glycyrrhiza glabra root extract as an active cosmetic substance impregnated on the carrier.
- the porosity of the particles is characterized by the specific surface area (also called SSA).
- the porous particles of the invention have an SSA measured according to the BET method greater than or equal to 8 m 2 / g.
- the BET method (BRUNAUER-EMMET-TELLER) is a method known to those skilled in the art. It is especially described in The Journal of the American Chemical Society, Vol. 60, page 309, February 1938, and corresponds to the international standard ISO 5794/1 (Appendix D).
- the specific surface area measured according to the BET method corresponds to the total surface area, that is to say it includes the surface formed by the pores.
- the particles are advantageously in the form of loose powder particles, that is to say that they are not grouped together in the form of agglomerates or aggregates.
- the polyamide particles advantageously have an average volume diameter Dv50 ranging from 3 to 15 ⁇ , and preferably from 5 to 12 ⁇ .
- This average volume diameter can be measured according to the usual techniques for example using a Coulter Multisizer II granulometer according to ISO 13319. From the particle size distribution, it is possible to determine the average diameter as well as the particle size dispersion (standard deviation) which measures the tightening of the distribution, with a standard deviation between 1 and 3 ⁇ , or often less than 2 ⁇ .
- This range of particle size associated with the porosity of the particles allows good penetration of the active agent into the stratum corneum of the epidermis, by slow diffusion.
- the polyamide particles are spheroidal, that is to say in the form of a spheroid which means: solid approximately spherical.
- polyamide used in the present application has a generic meaning, that is to say, it covers both homopolyamides, copolyamides, copolyesteramides and mixtures thereof.
- polyamides according to the invention correspond to the products of condensation of lactams, amino acids and / or diacids with diamines and, more generally, correspond to polymers formed by units linked together by amide groups.
- polyamides according to the invention may also be derived from the copolymerization of lactam (s) with one or more lactone (s) leading to copolyesteramides as described in patent EP 1 172396.
- copolyamides should be understood as “repetitive unit”.
- a repeating unit of the polyamide consists of the combination of a diacid with a diamine is particular. It is considered that it is the combination of a diamine and a diacid, that is to say the diamine-diacid couple (in equimolar quantity), which corresponds to the monomer. This is explained by the fact that, individually, the diacid or the diamine is only a structural unit, which is not enough on its own to polymerize.
- the particles according to the invention comprise at least two different monomers, they form a copolymer such as a copolyamide or a copolyesteramide.
- lactams By way of example of lactams, mention may be made of those having from 3 to 12 carbon atoms on the main ring and which may be substituted. Examples that may be mentioned include ⁇ , ⁇ -dimethylpropriolactam, ⁇ , ⁇ -dimethylpropriolactam, amylolactam, caprolactam, capryllactam, oenantholactam, 2-pyrrolidone and lauryllactam.
- diacid or dicarboxylic acid
- acids having between 4 and 18 carbon atoms Mention may be made, for example, of adipic acid, sebacic acid, azelaic acid and suberic acid. isophthalic acid, butanedioic acid, 1,4-cyclohexyldicarboxylic acid, terephthalic acid, sodium or lithium salt of sulphoisophthalic acid, dimerized fatty acids (these dimerized fatty acids have a content of at least 98% dimer and are preferably hydrogenated) and HOOC- (CH 2 ) 10 -COOH dodecanedioic acid.
- diamines By way of example of diamines, mention may be made of aliphatic diamines having from 6 to 12 atoms. They can be aryl and / or cyclic saturated. By way of example, mention may be made of hexamethylenediamine, piperazine, tetramethylenediamine, octamethylenediamine, decamethylene diamine, dodecamethylenediamine, 1,5-diaminohexane, 2,2,4-trimethyl-1, 6-diamino-hexane, diamine polyols, isophorone diamine (IPD), methyl pentamethylenediamine (MPDM), bis (aminocyclohexyl) methane (BACM), bis (3-methyl-4-aminocyclohexyl) methane (BMACM) methaxylyenediamine, bis-p-aminocyclohexylmethane and trimethylhexamethylenediamine.
- IPD isophorone
- amino acids there may be mentioned alpha-omega amino acids, such as aminocaproic acid, amino-7-heptanoic acid, amino-1 1 -undecanoic acid, n-heptyl-1 1 -aminoundecanoic acid and amino-12- dodecanoic.
- lactones there may be mentioned caprolactone, valerolactone and butyrolactone.
- the monomers preferably used in the invention are chosen from lactams such as for example lauryllactam, caprolactam, oenantholactam, capryllactam or their mixtures.
- lactams such as for example lauryllactam, caprolactam, oenantholactam, capryllactam or their mixtures.
- lauryllactam is used alone or in admixture with caprolactam.
- the polyamide particles according to the invention comprise, before impregnation, a molar percentage content of polyamide 12 in the range from 50% to 100%, preferably from 80% to 100%.
- the polyamide particles are polyamide 12 particles; or 6/12 copolyamide particles; or 8/12 copolyamide particles; or 10/12 copolyamide particles.
- it is particles of polyamide 12 and / or copolyamide 6/12.
- said polyamide-based powder particles are obtained at least in part by anionic polymerization, optionally by seeding with a mineral or organic filler, lactam (s) and / or lactone (s) in solution and / or suspension in a liquid organic.
- a mineral or organic filler lactam (s) and / or lactone (s) in solution and / or suspension in a liquid organic.
- lactam lactam
- lactone lactone
- polyamide 12 or contain mainly polyamide 12 units is the very high compatibility of this polymer with the constituents of the surface of the skin.
- the molecular structure of the polyamide 12 chains is in many ways similar to that of ceramides, cholesterol and fatty acids, the main constituents of the upper layers of the epidermis.
- the polyamide 12 chains contain hydrocarbon units with 12 carbon atoms, forming lipophilic fatty chains, similar to those of the lipid constituents of the skin. They thus ensure a great compatibility with the skin: softness, absence of irritation, excellent persistence.
- the amide functions of the polyamide chains 12 are polar functions which establish hydrogen bonds with the amide functions of the ceramides of the skin, reinforce the compatibility between the particles of the invention and the surface of the skin and prolong the adhesion particles on the surface of the skin. This prolongs the contact between the charged particles of active agent and the surface of the skin and optimizes the effectiveness of the agent on the surface of the skin.
- the extract of Glycyrrhiza glabra root (licorice) used in the invention contains in particular glabridin as active agent, that is to say the compound of the following formula:
- the root extract of Glycyrrhiza glabra is provided in combination with a solvent, thus forming an "active mixture".
- the solvent is preferably an alcohol, more preferably an alcohol of plant origin, and especially butylene glycol. Ethanol, ethylene glycol, propylene glycol and mixtures of different alcohols can also be used.
- concentration by weight of Glycyrrhiza glabra root extract in the solvent may be, for example, from 0.1 to 20%, in particular from 0.5 to 12%, or from 1 to 10%, and for example from about 3 to 8%.
- the mass proportion of polyamide particles may be from 50 to 90% and the mass proportion of active mixture may be from 10 to 50%; preferably, the mass proportion of polyamide particles may be 70 to 80% and the mass proportion of active mixture may be 20 to 30%.
- the mass proportion of glabridin in the composition according to the invention may be from 0.05 to 1%, and especially from 0.1 to 0.5%.
- Glabridin can be assayed by high performance liquid chromatography (HPLC).
- composition according to the invention may consist essentially, or even consist of, the polyamide particles and the active mixture described above.
- this composition may comprise various additives, such as pigments or preservatives.
- This composition may also comprise one or more other active substances, in particular cosmetically active substances, such as, for example, other substances that promote the lightening of the skin or the reduction of skin spots.
- active substances may in particular comprise kojic acid, ellagic acid, arbutin and its derivatives, hydroquinone, aminophenol derivatives, in particular N-cholesteryloxycarbonyl-para-aminophenol and N-ethyloxycarbonyl-para aminophenol, iminophenol derivatives, L-2-oxothiazolidine-4-carboxylic acid or procysteine, its salts and esters, calcium sulfonate D-pantheatin, arbutin and other derivatives of Glycyrrhiza glabra, ascorbic acid and its derivatives, especially ascorbyl glucoside, and plant extracts such as blackberry, skullcap and Bacopa monnieri extracts.
- the above composition is devoid of fatty phase (such as in particular oils and / or waxes and more generally phase which is fat at the temperature of 25 ° C and which consists of compounds without surfactant properties at meaning of the McCutcheon and CTFA dictionaries).
- fatty phase such as in particular oils and / or waxes and more generally phase which is fat at the temperature of 25 ° C and which consists of compounds without surfactant properties at meaning of the McCutcheon and CTFA dictionaries).
- composition according to the invention may be manufactured by contacting the polyamide particles with the active mixture described above.
- Document FR 2944443 provides examples of this type of process. Reference is made in particular (by analogy) to Example 1 of this document.
- composition according to the invention may be incorporated into a cosmetic product (or cosmetic composition), in particular of the lotion, cream, gel, water / oil emulsion or oil / water type (the oil being a silicone oil or not), loose powder , pressed powder (or compact powder), cast product (foundation, lipstick, etc.) or stick.
- a cosmetic product or cosmetic composition
- the oil being a silicone oil or not
- loose powder pressed powder (or compact powder)
- cast product foundation, lipstick, etc.
- the composition according to the invention may be incorporated in or mixed with a deodorant or antiperspirant product.
- the cosmetic product may be an anticler product, or a product for makeup of the body and / or face, or a foundation or a product for the care of the face or body.
- the cosmetic product may comprise, in addition to the composition according to the invention, one or more vehicles compatible with a cosmetic use, in particular of liquid type such as water, a hydroalcoholic solvent, one or more oils, or a combination thereof.
- a cosmetic use in particular of liquid type such as water, a hydroalcoholic solvent, one or more oils, or a combination thereof.
- an oil can be used a synthetic or natural oil, plant or animal origin. We can still include one or more waxes (synthetic or vegetable or animal).
- the cosmetic product may also comprise one or more additional active substances (in particular cosmetically active substances). It may also include fillers, for example talc, cellulose, fluorphlogopite. It may also include additives such as thickeners (especially xanthan gum), surfactants, dyes, pigments, perfumes, preservatives, physical and chemical sunscreens, sequestering agents, moisturizers such as polyols, and especially the glycerin, pH adjusters (acids and / or bases), antioxidants. According to one embodiment, the cosmetic product is devoid of white pigments.
- additional active substances in particular cosmetically active substances. It may also include fillers, for example talc, cellulose, fluorphlogopite. It may also include additives such as thickeners (especially xanthan gum), surfactants, dyes, pigments, perfumes, preservatives, physical and chemical sunscreens, sequestering agents, moisturizers such as polyols, and especially the glycerin, pH adjusters (
- the cosmetic product may nevertheless include nanoparticles as a sunscreen.
- the cosmetic product according to the invention can be manufactured conventionally, by simple mixing of the various compounds.
- composition according to the invention may for example be present in a mass proportion of 0.1 to 20% in the cosmetic product, preferably from 0.5 to 15%, more particularly preferably from 1 to 10%, especially from 2 to 8%, and for example from 3 to 5% approximately.
- composition according to the invention as well as the cosmetic products prepared from it can be used to obtain a uniform and radiant complexion, the lightening of the skin, the depigmentation of the skin, the reduction or prevention of brown spots or age spots on the skin.
- composition according to the invention as well as the cosmetic products prepared therefrom offer a long-term remanence.
- glabridin is used in the invention so as to inhibit tyrosinase activity and / or inhibit superoxide anion production and / or inhibit cyclooxygenase activity.
- composition of the invention also provides an effect of "soft focus” (soft focus in English terminology) of the skin, an effect of absorption of sebum, a binding or compacting effect (in the case of a product under compact powder form) and has an improved sensory profile.
- a formulation A is prepared for a cosmetic cream, of the oil-in-water type, for lightening the skin, having the following mass composition:
- Caprylic / capric triglycerides 5.0%.
- composition according to the invention 3.0%
- a formulation B for a cosmetic stick for the reduction of brown spots of the skin having the following mass composition:
- Caprylic / capric triglycerides 4.1%.
- Isostearyl isostearate 10.5%.
- Tetraacrylate / pentaerythrityl caprate 35.6%.
- Dimethicone / stearoyl disodium glutamate / aluminum hydroxide 1.5%.
- composition according to the invention 3.0%
- a formulation C is prepared for a pressed cosmetic powder for lightening the skin and smoothing imperfections, having the following mass composition:
- Isostearyl isostearate 3.0%.
- composition according to the invention 5.0%
- a formulation D is prepared for an alcoholic lotion for lightening the skin, intended to be applied after cleaning the skin and before any application of a cream:
- Hydrogenated castor oil PEG-40 1.00%.
- Cross-polymer-6 polyacrylate 0.10%.
- PEG / PPG-17/6 copolymer 3.00%.
- Composition according to the invention 1.0%.
- the composition according to the invention is manufactured from particles of copolyamide 6/12 (75% by weight) and extract of Glycyrrhiza glabra root in butylene glycol (25%).
- the particles have a mean diameter Dv50 of 10 ⁇ .
- the composition has a pH of 5 to 9, for example 7.5.
- Formulation A of Example 1 is tested on subjects for the reduction of the visibility of the brown spots of the skin, in comparison with a control formulation A 'identical to the formulation A with the exception of the composition of the invention , which is replaced by 3% water.
- the formulations were tested by daily application by volunteers, with the formulation A on one half of the face and the formulation A 'on the other half of the face as well as on the hands.
- the volunteers were twenty women with spots on their faces and hands.
- the effectiveness in reducing the visibility of brown spots is evaluated in three different ways: by image analysis, by chromameter measurement, and by clinical evaluation.
- the assessment is performed at 28 days and 56 days after the start of treatment.
- the indicated parameter is the angle ITA.
- a high value corresponds to a low spot intensity and vice versa.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15721764.7A EP3126010A1 (fr) | 2014-03-31 | 2015-03-31 | Composition cosmetique pour l'eclaircissement de la peau |
JP2016559896A JP2017509663A (ja) | 2014-03-31 | 2015-03-31 | 皮膚を明るくするための化粧品組成物 |
US15/300,595 US20170172910A1 (en) | 2014-03-31 | 2015-03-31 | Cosmetic composition for lightening the skin |
CN201580017200.0A CN106456523A (zh) | 2014-03-31 | 2015-03-31 | 用于使皮肤色泽变淡的化妆品组合物 |
KR1020167030503A KR101924705B1 (ko) | 2014-03-31 | 2015-03-31 | 피부 라이트닝을 위한 화장용 조성물 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1452792A FR3019040B1 (fr) | 2014-03-31 | 2014-03-31 | Composition cosmetique pour l'eclaircissement de la peau |
FR1452792 | 2014-03-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015150694A1 true WO2015150694A1 (fr) | 2015-10-08 |
Family
ID=51014472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2015/050834 WO2015150694A1 (fr) | 2014-03-31 | 2015-03-31 | Composition cosmetique pour l'eclaircissement de la peau |
Country Status (7)
Country | Link |
---|---|
US (1) | US20170172910A1 (fr) |
EP (1) | EP3126010A1 (fr) |
JP (2) | JP2017509663A (fr) |
KR (1) | KR101924705B1 (fr) |
CN (1) | CN106456523A (fr) |
FR (1) | FR3019040B1 (fr) |
WO (1) | WO2015150694A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3042415B1 (fr) * | 2015-10-20 | 2020-11-20 | Laboratoires De Biologie Vegetale Yves Rocher | Utilisation d'un extrait de reglisse (glycyrrhizza glabra l.) pour une action d'hydratation de la peau, de ses annexes ou des muqueuses |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0192515A1 (fr) | 1985-01-30 | 1986-08-27 | Elf Atochem S.A. | Procédé de fabrication de poudre de polyamide |
WO1996021422A1 (fr) | 1995-01-11 | 1996-07-18 | Mary Kay Inc. | Compositions cosmetiques anhydres contenant des agents actifs sur le plan dermatologique |
US5609875A (en) * | 1994-03-17 | 1997-03-11 | Fischer Pharmaceuticals Ltd. | Skin whitening composition |
WO1998058628A1 (fr) | 1997-06-20 | 1998-12-30 | Mary Kay Inc. | Composition cosmetique renfermant un agent de blanchiment et un desquamant |
EP1172396A1 (fr) | 2000-07-11 | 2002-01-16 | Atofina | Procédé de préparation de poudres poreuses de copolyesteramides et poudres ainsi obtenues |
US20020176843A1 (en) | 2001-03-23 | 2002-11-28 | L'oreal | Polyamide particles as anti-irritant agents |
EP1493433A1 (fr) | 2003-06-26 | 2005-01-05 | L'oreal | Particules poreuses chargées en composé(s) actif(s) cosmétique(s) ou pharmaceutique(s) |
EP1637124A1 (fr) * | 2004-09-16 | 2006-03-22 | L'oreal | Utilisation cosmétique d'une composition renfermant un dérivé d'acide ascorbique et des particules de polyamide |
WO2006037665A1 (fr) | 2004-10-08 | 2006-04-13 | L'oreal | Poudre compacte contenant des particules de polyamide renfermant un agent actif |
FR2910900A1 (fr) | 2006-12-28 | 2008-07-04 | Arkema France | Procede de preparation de poudre de polyamide par polymerisation anionique |
CN101606890A (zh) * | 2008-06-21 | 2009-12-23 | 中山市嘉丹婷日用品有限公司 | 一种皮肤美白组合物 |
FR2944443A1 (fr) | 2009-04-21 | 2010-10-22 | Arkema France | Procede de fabrication de particules de poudre libre a base de polyamide impregnee, et particules de poudre libre a base de polyamide ayant une teneur d'au moins 25% en poids d'au moins un agent cosmetique ou pharmaceutique |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH068249B2 (ja) * | 1988-06-09 | 1994-02-02 | 丸善製薬株式会社 | メラニン生成抑制外用剤 |
JP3091040B2 (ja) * | 1993-02-12 | 2000-09-25 | 丸善製薬株式会社 | 皮膚化粧料 |
US20060039938A1 (en) * | 2004-08-17 | 2006-02-23 | L'oreal | Cosmetic method of caring for greasy skin |
FR2874321B1 (fr) * | 2004-08-17 | 2010-11-26 | Oreal | Composition topique comprenant des particules poreuses chargees et un compose absorbant le sebum |
KR100772334B1 (ko) * | 2005-09-30 | 2007-11-01 | 주식회사 코리아나화장품 | 빈랑자 추출물을 함유하는 피부 주름 개선 및 피부 미백의 이중기능성 화장료 조성물 |
US20090263434A1 (en) | 2005-12-14 | 2009-10-22 | Ube Industries, Ltd. | Powder composed of inorganic compound-loaded polyamide porous particle |
FR2914856B1 (fr) * | 2007-04-12 | 2012-08-03 | Arkema France | Composition cosmetique comprenant une poudre fine |
MX299318B (es) * | 2007-11-19 | 2012-05-18 | Stiefel Laboratories | Composiciones cosmeticas topicas para aclarar la piel, y metodos de uso de las mismas. |
FR2927626B1 (fr) * | 2008-02-15 | 2011-02-25 | Arkema France | Poudre fine de polyamide issu de matieres renouvelables et procede de fabrication d'une telle poudre. |
JP5888937B2 (ja) * | 2011-10-31 | 2016-03-22 | 富士フイルム株式会社 | 化粧料 |
-
2014
- 2014-03-31 FR FR1452792A patent/FR3019040B1/fr not_active Expired - Fee Related
-
2015
- 2015-03-31 US US15/300,595 patent/US20170172910A1/en not_active Abandoned
- 2015-03-31 EP EP15721764.7A patent/EP3126010A1/fr not_active Ceased
- 2015-03-31 JP JP2016559896A patent/JP2017509663A/ja active Pending
- 2015-03-31 CN CN201580017200.0A patent/CN106456523A/zh active Pending
- 2015-03-31 WO PCT/FR2015/050834 patent/WO2015150694A1/fr active Application Filing
- 2015-03-31 KR KR1020167030503A patent/KR101924705B1/ko active IP Right Grant
-
2018
- 2018-12-06 JP JP2018228730A patent/JP2019069956A/ja active Pending
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0192515A1 (fr) | 1985-01-30 | 1986-08-27 | Elf Atochem S.A. | Procédé de fabrication de poudre de polyamide |
US5609875A (en) * | 1994-03-17 | 1997-03-11 | Fischer Pharmaceuticals Ltd. | Skin whitening composition |
WO1996021422A1 (fr) | 1995-01-11 | 1996-07-18 | Mary Kay Inc. | Compositions cosmetiques anhydres contenant des agents actifs sur le plan dermatologique |
WO1998058628A1 (fr) | 1997-06-20 | 1998-12-30 | Mary Kay Inc. | Composition cosmetique renfermant un agent de blanchiment et un desquamant |
EP1172396A1 (fr) | 2000-07-11 | 2002-01-16 | Atofina | Procédé de préparation de poudres poreuses de copolyesteramides et poudres ainsi obtenues |
US20020176843A1 (en) | 2001-03-23 | 2002-11-28 | L'oreal | Polyamide particles as anti-irritant agents |
EP1493433A1 (fr) | 2003-06-26 | 2005-01-05 | L'oreal | Particules poreuses chargées en composé(s) actif(s) cosmétique(s) ou pharmaceutique(s) |
EP1637124A1 (fr) * | 2004-09-16 | 2006-03-22 | L'oreal | Utilisation cosmétique d'une composition renfermant un dérivé d'acide ascorbique et des particules de polyamide |
WO2006037665A1 (fr) | 2004-10-08 | 2006-04-13 | L'oreal | Poudre compacte contenant des particules de polyamide renfermant un agent actif |
FR2910900A1 (fr) | 2006-12-28 | 2008-07-04 | Arkema France | Procede de preparation de poudre de polyamide par polymerisation anionique |
CN101606890A (zh) * | 2008-06-21 | 2009-12-23 | 中山市嘉丹婷日用品有限公司 | 一种皮肤美白组合物 |
FR2944443A1 (fr) | 2009-04-21 | 2010-10-22 | Arkema France | Procede de fabrication de particules de poudre libre a base de polyamide impregnee, et particules de poudre libre a base de polyamide ayant une teneur d'au moins 25% en poids d'au moins un agent cosmetique ou pharmaceutique |
Non-Patent Citations (1)
Title |
---|
THE JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 60, February 1938 (1938-02-01), pages 309 |
Also Published As
Publication number | Publication date |
---|---|
KR20160132121A (ko) | 2016-11-16 |
CN106456523A (zh) | 2017-02-22 |
US20170172910A1 (en) | 2017-06-22 |
KR101924705B1 (ko) | 2018-12-03 |
FR3019040B1 (fr) | 2016-03-11 |
FR3019040A1 (fr) | 2015-10-02 |
JP2017509663A (ja) | 2017-04-06 |
EP3126010A1 (fr) | 2017-02-08 |
JP2019069956A (ja) | 2019-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0755674B1 (fr) | Composition stable contenant de l'acide ascorbique | |
EP3174603B1 (fr) | Extrait de camellia japonica et compositions cosmétiques le comprenant | |
EP2694022B1 (fr) | Composition cosmétique comprenant un composé d'acide cucurbique et un mélange de polymères sulfonique et acrylique | |
EP2421494B1 (fr) | Procede de fabrication de particules de poudre libre a base de polyamide impregnee d'au moins un agent cosmetique ou pharmaceutique, et particules de poudre libre a base de polyamide ayant une teneur d'au moins 25% en poids d'au moins un agent cosmetique ou pharmaceutique | |
FR2992185A1 (fr) | Composition a effet matifiant comprenant des particules d'aerogels hydrophobes et des particules de silice | |
EP1837013B1 (fr) | Composition comprenant de l'hydroxyapatite et un sel de calcium pour renforcer la fonction barrière de la peau et/ou des semi-muqueuses. | |
WO2007122343A1 (fr) | Composition cosmetique de type masque rincable pour le soin de la peau | |
FR2820315A1 (fr) | Composition topique anti-pollution | |
FR2914856A1 (fr) | Composition cosmetique comprenant une poudre fine | |
FR2767694A1 (fr) | Systeme a base de derive d'acide phosphonique et de metabisulfite pour stabiliser l'acide ascorbique et composition contenant un tel systeme | |
FR2902340A1 (fr) | Composition cosmetique a usage topique comprenant du wasabi | |
EP1559396A1 (fr) | Procédé de préparation d'une composition pour le traitement cosmétique des matiéres kératiniques à partir de fluide sous pression et de composés cosmétiquement actifs liquids piegés par des particules | |
FR2928541A1 (fr) | Composition cosmetique comprenant un compose d'acide salicylique | |
FR3010306A1 (fr) | Composition cosmetique comprenant un systeme lamellaire | |
WO2015150694A1 (fr) | Composition cosmetique pour l'eclaircissement de la peau | |
FR2976485A1 (fr) | Utilisation comme agent anti-transpirant d'un polymere hydrodispersible floculant comportant des groupements amines non quaternises | |
CA2353721A1 (fr) | Composition cosmetique deodorante | |
FR2928540A1 (fr) | Composition cosmetique comprenant un compose d'acide ascorbique | |
FR3046066A1 (fr) | Composition a base d’acide spiculisporique | |
FR2920299A1 (fr) | Utilisation cosmetique d'une association synergique d'un derive phenanthrenaol et de palmitate d'ascrobyle a titre d'agent antioxydant | |
WO2021224575A1 (fr) | Composition cosmetique comprenant au moins une algue rouge calcaire | |
FR2835427A1 (fr) | Composition cosmetologique et/ou dermatologique a base d'extrait de barbatimao | |
JP2019194192A (ja) | ツバキ(Camellia japonica)抽出物およびそれを含有する化粧品組成物 | |
EP4035653A1 (fr) | Extrait huileux de fleurs de gardenia jasminoides et compositions cosmétiques le comprenant | |
FR2885298A1 (fr) | Compositions cosmetiques destinees a une application topique comprenant du stearyl fumarate de sodium. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15721764 Country of ref document: EP Kind code of ref document: A1 |
|
REEP | Request for entry into the european phase |
Ref document number: 2015721764 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2015721764 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2016559896 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 15300595 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 20167030503 Country of ref document: KR Kind code of ref document: A |